New drug aims for Long-Term relief from chronic hives
NCT ID NCT06736262
Summary
This study is checking the long-term safety and effectiveness of the drug briquilimab for people with chronic hives (urticaria). It is open to people who have already taken part in a previous Jasper Therapeutics trial for this condition. The main goal is to see how safe the drug is over a longer period and if it continues to help control hives.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URTICARIA CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site 101
Baltimore, Maryland, 21224, United States
-
Investigative Site 103
Cincinnati, Ohio, 45236, United States
-
Investigative Site 105
San Diego, California, 92123, United States
-
Investigative Site 108
Little Rock, Arkansas, 72205, United States
-
Investigative Site 109
Boise, Idaho, 83706, United States
-
Investigative Site 110
Indianapolis, Indiana, 46250, United States
-
Investigative Site 111
Murray, Utah, 84107, United States
-
Investigative Site 115
Seattle, Washington, 98101, United States
-
Investigative Site 116
Tampa, Florida, 33613, United States
-
Investigative Site 118
Birmingham, Alabama, 35244, United States
-
Investigative Site 121
White Marsh, Maryland, 21162, United States
-
Investigative Site 123
Lafayette, Louisiana, 70508, United States
-
Investigative Site 124
Normal, Illinois, 61761, United States
-
Investigative Site 201
Berlin, 12203, Germany
-
Investigative Site 202
Marburg, Hesse, 35043, Germany
-
Investigative Site 204
Münster, North Rhine-Westphalia, 48149, Germany
-
Investigative Site 206
Lübeck, Schleswig-Holstein, 23538, Germany
-
Investigative Site 209
Dresden, Saxony, 01307, Germany
-
Investigative Site 210
München, Bavaria, 80802, Germany
Conditions
Explore the condition pages connected to this study.